Aspen Pharmacare Holdings Limited (JSE:APN)

Aspen Pharmacare Holdings Ratios and Metrics

Market cap in millions ZAR. Fiscal year is July - June.

Total Valuation

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 6, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Market Capitalization	73,475	69,658	53,079	103,810	81,701	62,047
Market Cap Growth	70.72%	31.24%	-48.87%	27.06%	31.68%	-15.97%
Enterprise Value	73,046	96,981	81,746	128,328	100,452	81,357
Last Close Price	166.39	154.63	115.21	220.81	170.35	126.00

Price Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 6, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
PE Ratio	27.92	26.32	-	23.57	15.63	9.56
Forward PE	14.15	13.71	9.58	12.68	10.44	7.34
PS Ratio	2.11	2.00	1.50	2.32	2.01	1.61
PB Ratio	0.91	0.87	0.63	1.22	0.95	0.88
P/TBV Ratio	1.89	1.79	3.71	7.46	4.45	4.68
P/FCF Ratio	15.58	14.77	20.55	33.40	24.83	18.19
P/OCF Ratio	10.70	10.14	10.29	16.68	14.80	11.55
PEG Ratio	-	1.26	63.89	0.89	0.66	0.46

EV Ratios

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 6, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
EV/Sales Ratio	2.09	2.78	2.31	2.87	2.47	2.11
EV/EBITDA Ratio	10.32	14.12	13.78	12.49	9.86	8.19
EV/EBIT Ratio	13.92	18.48	18.52	14.47	11.25	9.31
EV/FCF Ratio	15.49	20.56	31.65	41.29	30.53	23.85

Financial Efficiency

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 6, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Debt / Equity Ratio	0.19	0.19	0.43	0.43	0.34	0.31
Debt / EBITDA Ratio	2.20	2.20	5.86	3.47	2.82	2.20
Debt / FCF Ratio	3.30	3.30	13.98	11.73	8.90	6.52
Net Debt / Equity Ratio	0.00	0.00	0.35	0.28	0.21	0.23
Net Debt / EBITDA Ratio	-0.06	-0.06	5.01	2.35	1.80	1.62
Net Debt / FCF Ratio	-0.09	-0.09	11.50	7.76	5.58	4.71
Asset Turnover	0.29	0.29	0.26	0.33	0.33	0.35
Inventory Turnover	1.25	1.25	1.15	1.35	1.24	1.40
Quick Ratio	1.66	1.66	1.17	1.06	1.06	0.79
Current Ratio	2.54	2.54	2.21	1.81	1.92	1.48
Return on Equity (ROE)	-1.07%	-1.07%	-3.21%	5.15%	6.65%	9.50%
Return on Assets (ROA)	2.69%	2.69%	2.01%	4.06%	4.54%	4.94%
Return on Invested Capital (ROIC)	6.57%	5.40%	3.95%	6.40%	7.43%	8.25%
Return on Capital Employed (ROCE)	5.70%	5.70%	3.70%	7.70%	8.00%	9.90%

Yields

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Nov 6, 2026	Jun 30, 2026	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022
Earnings Yield	3.58%	3.80%	-2.04%	4.24%	6.40%	10.46%
FCF Yield	6.42%	6.77%	4.87%	2.99%	4.03%	5.50%
Dividend Yield	1.39%	1.47%	1.76%	1.54%	1.86%	2.34%
Payout Ratio	35.55%	35.55%	-	34.63%	27.83%	18.43%
Buyback Yield / Dilution	-0.02%	-0.02%	0.04%	-	1.94%	0.77%
Total Shareholder Return	1.37%	1.45%	1.81%	1.54%	3.81%	3.10%

Data Source: S&P Global Market Intelligence Last updated: Oct 2, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Nov 8, 2026

Data Sources Report a data error